国家要免费拯救肝人啊（肝不正常的人这里统称为肝人）

StephenW

limi2011321 发表于 2011-4-8 14:07
回复 springa 的帖子

请高人指教！

I will give you an idea:

1. Go to the hospital where you had your operation.
2. Get a  list of patients who had operation at the same day(+/- 1day) and who had blood transfusion as you did.
3. Try to find out whether any of these patients also contracted Hep C as you did.
4. If you can find one or more, then you should contact a lawyer to investigate further for you.

Second idea:
You really need to find someone who worked at the hospital around the time you had your operation. Ask this person to tell you privately whether the hospital recorded cases of Hep C patients at the time. All hospitals are required to report cases of Hep C to the authority. If the answer is yes, then contact a lawyer to investigate further for you.

Good luck.

limi2011321

回复 StephenW 的帖子

谢谢您的指导！我会去为这个努力奋斗！

limi2011321

回复 limi2011321 的帖子

如果胜利，请你吃饭！你不会不吃吧？！呵呵   谢谢！！！

StephenW

limi2011321 发表于 2011-4-8 14:25
回复 limi2011321 的帖子

如果胜利，请你吃饭！你不会不吃吧？！呵呵   谢谢！！！ ...

I will come, for sure.

limi2011321

回复 StephenW 的帖子

谢谢您的支持和关注！！！

StephenW

limi2011321 发表于 2011-4-8 18:19
回复 StephenW 的帖子

谢谢您的支持和关注！！！

This is from a medical website in the USA.  In China, I would say "In the early 1990s and before.."


"Before 1990, hepatitis C was spread through contact with infected blood products. It is often spread through the sharing needles or straws during drug use. Among immigrants to the U.S., the virus may have been transmitted by the use of non-sterile syringes used for giving vaccines."

http://ivanhoe.com/channels/p_channelstory.cfm?storyid=26722

limi2011321

回复 StephenW 的帖子

谢谢您的关注！您发的地址，我电脑打不开，不知道是为什么，页面一片漆黑，没任何文字和图片！

StephenW

limi2011321 发表于 2011-4-8 20:53
回复 StephenW 的帖子

谢谢您的关注！您发的地址，我电脑打不开，不知道是为什么，页面一片漆黑，没任何文 ...

再试一次.

StephenW

limi2011321 发表于 2011-4-8 20:53
回复 StephenW 的帖子

谢谢您的关注！您发的地址，我电脑打不开，不知道是为什么，页面一片漆黑，没任何文 ...

Reported April 1, 2011 Drug cocktail Offers New Hope For Hepatitis C Patients(Ivanhoe Newswire) -- People who suffer from hepatitis C may be in luck—according to researchers at Henry Ford Hospital, a new three-drug cocktail eliminates the virus more effectively than the current two-drug treatment. At least 3.2 million Americans have hepatitis C, which is a chronic viral disease that affects the liver. Most people with the virus don’t show any symptoms for years, and when symptoms do show up, it is often too late to treat. According the Centers for Disease Control and Prevention, more than 12,000 people a year die from the liver disease and liver cancer associated with hepatitis C. Before 1990, hepatitis C was spread through contact with infected blood products. It is often spread through the sharing needles or straws during drug use. Among immigrants to the U.S., the virus may have been transmitted by the use of non-sterile syringes used for giving vaccines. There is currently no vaccine for hepatitis C, and until now the standard for hepatitis C medication was a two-drug regimen—peginterferon-ribavirin. The third drug now in the mix, boceprevir, is a protease inhibitor: it specifically targets and inhibits the replication of the hepatitis C virus. To test the effectiveness of boceprevir in addition to peginterferon-ribavirin (the usual two-drug course), the participants in the study were divided into three groups. For the first four weeks of the study, all three groups received the usual peginterferon-ribavirin regimen for hepatitis C. After the four weeks, group 1 (the control group) continued on the same two-drug course for 44 more weeks, while group two received boceprevir and the two usual drugs for 32 additional weeks. Patients in group two with a detectable hepatitis C virus level at week 8 were given a placebo and peginterferon-ribavirin for an extra twelve weeks. Group three received the new three-drug cocktail for 44 weeks. The results of the study showed the rate of the loss of the virus, or sustained virologic response, was much higher in the two groups treated with boceprevir than in the control group (59% and 66% for groups two and three, respectively, as opposed to 21% for the control group). The sustained virologic response was also high among patients with undetectable levels of the virus at week 8: after 32 weeks, the sustained virologic response was 86%, and after 44 weeks, 88%. A sustained virologic response usually means that the virus has been cured. Stuart C. Gordon, M.D., co-author of the study and section chief for the Division of Hepatology at Henry Ford Hospital, was quoted as saying, “We will soon have a new standard of treatment for hepatitis C patients. This study ushers in a new era of drug development that will provide a host of antiviral agents to treat hepatitis C, and we are now witnessing dramatic and rapid advances in how we will be able to treat these patients.” SOURCE: The New England Journal of Medicine, March 31, 2011 More InformationWant to be the FIRST TO KNOW? >Click Herefor a free weekly email with Ivanhoe's latest Medical Breakthroughs.

For a FREE weekly e-mail update of upcoming Medical Breakthroughs from Ivanhoe.com, sign up at http://www.ivanhoe.com/FirstToKnow/.

[email protected] Copyright              © 2011 Ivanhoe Broadcast News, Inc. 2745 West Fairbanks             Avenue Winter Park, Florida 32789 (407) 740-0789             P.O. Box 865 Orlando, Florida 32802

limi2011321

回复 StephenW 的帖子

谢谢您的关注！